[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 174.129.114.211. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 724
Citations 0
Comment & Response
January 27, 2015

Ethical Testing of Experimental Ebola Treatments

Author Affiliations
  • 1Obafemi Awolowo University, Ile-Ife, Nigeria
  • 2School of Public Health and Community Medicine, University of New South Wales, Sydney, Australia
  • 3Department of Anthropology, University of California, Irvine
JAMA. 2015;313(4):421. doi:10.1001/jama.2014.17256

To the Editor In his Viewpoint, Dr Joffe1 sought to justify the need for randomization of experimental drugs used for the management of the Ebola crisis due to the need for scientific information. He explicitly argued against the compassionate use of experimental interventions.

Instead, we argue for compassionate use of experimental interventions for Ebola management in ways that do not legitimize inequitable access to resources, especially in countries where human rights violations routinely occur. We prefer access to experimental drugs through a first-come, first-served approach for allocating scarce resources.2

First Page Preview View Large
First page PDF preview
First page PDF preview
×